Categories
Connect with us on LinkedIn
Castor Catalyst is the first to market to show industry-leading data extraction accuracy in a sponsor-audit-friendly technical approach
Castor Catalyst, Castor's AI-driven clinical data platform, reads data directly from source records and proposes each value for...
When patients enroll themselves, studies fill about six times faster
Self-selected and self-served: does patient-led digital enrollment predict downstream data completeness in real-world evidence studies?
Inside the Curavit and Lindus deal: what unified US and European trial delivery really takes
Curavit has acquired Lindus Health's CRO assets, bringing US and European trial delivery under one roof while Lindus...
Does real-world evidence still need the physician? A live debate at the RWE crossroad
Anthropic's CEO says AI could cure most disease within a decade. The harder question is what happens to...
The RWE Crossroad: the physician, the patient, or the machine?
Real-world evidence has more ways than ever to capture a patient's story: directly from patients, from medical records...
What nine years of MDR experience is changing about PMCF planning, and where AI fits in
Nine years into EU MDR, the conversation has moved past "how do we collect PMCF data" to a...
The 2027 RWE Playbook
Most RWE programs weren't built for 2027. They were built for 2019 — before FDA issued device-specific guidance...
End the surgical data entry burden: AI-assisted, human-supervised, 80% faster
On May 6, 2026, Castor and SAGES are hosting a 30-minute session on ending the surgical data entry...
Beyond the EHR: meeting the FDA’s new real-world evidence standards
The FDA’s December 2025 device guidance and March 2026 ICH M14 adoption raise the bar for RWE programs....
Better Evidence Starts with Better Infrastructure
Meet Castor at ISPOR US 2026 | May 17-20 | Philadelphia, PA
Schedule a meeting with the Castor team at ISPOR US 2026. See Castor Catalyst AI for real-world evidence...
Phase 4 and real-world evidence: not a spectrum, a strategic choice
Phase 4 is a post-approval interventional trial that fulfills regulatory commitments. Real-world evidence spans PASS, PAES, HEOR, natural...
Castor Joins C-Path eCOA Consortium, Surpassing 300 Industry Study Milestone
Castor joins the Critical Path Institute (C-Path) eCOA Consortium, bringing insights from 300+ industry studies to advance participant-centric...
ICH E6(R3) is here: what your centralized monitoring strategy needs right now
ICH E6(R3) is in effect. Castor's recap covers centralized monitoring, sponsor accountability, and closing the biotech RBQM gap.
SCOPE 2026 Meet us at Booth #1612
February 2nd – 5th | Rosen Shingle Creek in Orlando, Florida
Join Castor at SCOPE US 2026, February 2-5 at Orlando's Rosen Shingle Creek. Discover how our "self-driving" clinical...
Castor Catalyst
Castor Catalyst revolutionizes real-world evidence generation by automating data extraction from EHR and claims data. Built with AI-driven...
Castor Catalyst: Launching Self-Driving Clinical Trials with Google Cloud AI
Castor has launched Castor Catalyst, an innovative AI-powered platform developed in collaboration with Google Cloud. Built on Google's...
Castor Catalyst
See how Castor Catalyst automates the transformation of real-world data into submission-ready study datasets. In this on-demand demo,...
Automated Evidence Generation for Regulatory-Grade Real-World Data
Manual data abstraction can’t keep up with new FDA and EMA RWE standards. This whitepaper explains how automated...